Recombinant multi-species MGEA5/OGA protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine MGEA5/OGA protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The dynamic modification of cytoplasmic and nuclear proteins by O-linked N-acetylglucosamine (O-GlcNAc) addition and removal on serine and threonine residues is catalyzed by OGT (MIM 300255), which adds O-GlcNAc, and MGEA5, a glycosidase that removes O-GlcNAc modifications (Gao et al., 2001 [PubMed 11148210]).[supplied by OMIM, Mar 2008]
The Alternative Names of target: Beta-N-acetylglucosaminidase,Beta-N-acetylhexosaminidase,Beta-hexosaminidase,Hy5,MEA5,MGEA5,Meningioma-expressed antigen 5,Mgea5,N-acetyl-beta-D-glucosaminidase,N-acetyl-beta-glucosaminidase,NCOAT,Ncoat,Nuclear cytoplasmic O-GlcNAcase and acetyltransferase (NCOAT),OGA,Oga,Protein O-GlcNAcase

Target products collectionGo to MGEA5/OGA products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-T19567-Ag-1/ GM-Tg-hg-T19567-Ag-2 Human MGEA5/OGA protein Human
GM-Tg-rg-T19567-Ag-1/ GM-Tg-rg-T19567-Ag-2 Rat MGEA5/OGA protein Rat
GM-Tg-mg-T19567-Ag-1/ GM-Tg-mg-T19567-Ag-2 Mouse MGEA5/OGA protein Mouse
GM-Tg-cynog-T19567-Ag-1/ GM-Tg-cynog-T19567-Ag-2 Cynomolgus/Rhesus macaque MGEA5/OGA protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-T19567-Ag-1/ GM-Tg-felg-T19567-Ag-2 Feline MGEA5/OGA protein Feline
GM-Tg-cang-T19567-Ag-1/ GM-Tg-cang-T19567-Ag-2 Canine MGEA5/OGA protein Canine
GM-Tg-bovg-T19567-Ag-1/ GM-Tg-bovg-T19567-Ag-2 Bovine MGEA5/OGA protein Bovine
GM-Tg-equg-T19567-Ag-1/ GM-Tg-equg-T19567-Ag-2 Equine MGEA5/OGA protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-T19567-Ag-1/ GM-Tg-hg-T19567-Ag-2; GM-Tg-rg-T19567-Ag-1/ GM-Tg-rg-T19567-Ag-2;
GM-Tg-mg-T19567-Ag-1/ GM-Tg-mg-T19567-Ag-2; GM-Tg-cynog-T19567-Ag-1/ GM-Tg-cynog-T19567-Ag-2;
GM-Tg-felg-T19567-Ag-1/ GM-Tg-felg-T19567-Ag-2; GM-Tg-cang-T19567-Ag-1/ GM-Tg-cang-T19567-Ag-2;
GM-Tg-bovg-T19567-Ag-1/ GM-Tg-bovg-T19567-Ag-2; GM-Tg-equg-T19567-Ag-1/ GM-Tg-equg-T19567-Ag-2
Products Name MGEA5/OGA protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name MGEA5/OGA
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine MGEA5/OGA protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.